The aim of the article is to present the evolution of professional liability in psychiatry from law 36 of 1904 to today. Through an examination of the doctrinal positions and of the jurisprudential expression it was possible to highlight three distinct phases in which professional responsibility has declined over the years. A custodial phase, in which the spirit that animated the law of psychiatric assistance was inspired by principles of social defense and the responsibility of the psychiatrist was recognized mainly in the lack of custody of the psychiatric patient. A phase of indulgence, in which, like other disciplines, the psychiatrist was recognized with "reduced impunity" due to an alleged "special difficulty" in exercising the medical profession. A phase of empowerment, in which the doctor in general, and the psychiatrist in particular, was confronted with empowering positions that led to convictions. An examination of the application of the guarantee position to psychiatry allows us to highlight current difficulties, sometimes a legacy of the past.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1708/3504.34899 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Objective: Aim: To determine the specifics of criminal liability for disclosing information about a medical examination for detection of infection with the human immunodeficiency virus or another incurable infectious disease under the criminal legislation of Poland and Ukraine in order to improve the legal protection of the interests of people living with HIV.
Patients And Methods: Materials and Methods: The authors used the decisions of national courts in the field of ensuring the information security of a person living with the immunodeficiency virus, international and national legal acts of Ukraine and Poland. The study was carried out on the basis of a systematic approach using the methods of dialectical and formal logic, general scientific and special legal research methods.
Unraveling the genetic links between depression and type 2 diabetes.
Prog Neuropsychopharmacol Biol Psychiatry
January 2025
Institute of Neuropsychiatry, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing 210029, China; Department of Psychiatry, The Affiliated Brain Hospital of Nanjing Medical University, Nanjing 210029, China. Electronic address:
Background: Type 2 diabetes (T2D) is a chronic metabolic disorder that has high comorbidity with mental disorders. The genetic relationships between T2D and depression are far from being well understood.
Methods: We performed genetic correlation, polygenic overlap, Mendelian randomization (MR) analyses, cross-trait meta-analysis, and Bayesian colocalization analysis to assess genetic relationships between T2D and depression, in the forms of major depressive disorder (MDD) and depressed affect (DAF).
Polygenic overlap with granulocyte counts identifies novel loci for clozapine metabolism and clozapine-induced agranulocytosis.
Neuropsychopharmacology
January 2025
Centre for Precision Psychiatry, Division of Mental Health and Addiction, Oslo University Hospital, and Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
While clozapine is the most effective antipsychotic drug, its use is limited due to hematological adverse effects involving the reduction of granulocyte counts with potential life-threatening agranulocytosis. It is not yet possible to predict or prevent the risk of agranulocytosis, and the mechanisms are unknown but likely related to clozapine metabolism. Genome-wide association studies (GWASs) of clozapine metabolism and clozapine-induced agranulocytosis have identified few genetic loci.
View Article and Find Full Text PDFAssociations among externalizing psychopathology, personality, and behavioral traits: Models of an externalizing spectrum in youth.
Personal Disord
January 2025
Department of Psychology, Emory University.
Consistent evidence has documented the cross-sectional and longitudinal associations of externalizing psychopathology with personality and behavioral traits, suggesting the presence of a broad, underlying liability to externalizing. In one of the first studies of its kind, we use a large, representative sample of youth ( = 2,245 twins and their siblings) to evaluate the evidence of an externalizing spectrum model, which includes psychopathology, personality, and behavioral traits and spans normal and pathological variation. We examine evidence for the inclusion of 15 candidate traits, from the domains of general and pathological personality, temperament, and aggression, in a model that includes dimensions of common childhood externalizing psychopathology.
View Article and Find Full Text PDFHigh-reward, high-risk technologies? An ethical and legal account of AI development in healthcare.
BMC Med Ethics
January 2025
Faculty of Law, University of Montreal, Ch de la Tour, Montreal, QC, H3T 1J7, Canada.
Background: Considering the disruptive potential of AI technology, its current and future impact in healthcare, as well as healthcare professionals' lack of training in how to use it, the paper summarizes how to approach the challenges of AI from an ethical and legal perspective. It concludes with suggestions for improvements to help healthcare professionals better navigate the AI wave.
Methods: We analyzed the literature that specifically discusses ethics and law related to the development and implementation of AI in healthcare as well as relevant normative documents that pertain to both ethical and legal issues.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!